drugset / Trial / NCT00557544

Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood

NCT00557544

Phase 3 Withdrawn IRCCS Burlo Garofolo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Randomized double blind trial with the aim to estimate the effectiveness of 3 therapeutic regimes per os on migraine pain: * metoclopramide 0,15 mg/kg + placebo * metoclopramide 0,15 mg/Kg + ketoprofen 1 mg/kg * ketoprofen 1 mg/Kg + placebo Intensity of pain will be measured with linear 1-10 scale or analogic McGrath type scale every 20 min. The main objective is the evaluation of healing times from pain in the 3 groups

Timeline

Start
2009-06
Primary completion
2009-12
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule 1 mg/kg Oral
Subject Metoclopramide Small molecule 0.15 mg/kg Oral

Indications